Filipits, Martin <br/><br/>
A new molecular predictor of distant recurrence in ER-positive, HER2-negative breast cancer adds independent information to conventional clinical risk factors.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  Sep 2011 
 - 6012-20 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1557-3265 
<br/><br/><label>Standard No.: </label>10.1158/1078-0432.CCR-11-0926  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Breast Neoplasms--genetics<br/>Female<br/>Gene Expression Profiling--methods<br/>Humans<br/>Kaplan-Meier Estimate<br/>Neoplasm Metastasis<br/>Prognosis<br/>Proportional Hazards Models<br/>Receptor, ErbB-2--genetics<br/>Receptors, Estrogen--genetics<br/>Reproducibility of Results<br/>Risk Factors